HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soumitro Pal Selected Research

Mechanistic Target of Rapamycin Complex 2

12/2008CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Soumitro Pal Research Topics

Disease

26Neoplasms (Cancer)
12/2023 - 06/2003
21Kidney Neoplasms (Kidney Cancer)
12/2023 - 02/2004
4Renal Cell Carcinoma (Grawitz Tumor)
12/2023 - 01/2017
3Neoplasm Metastasis (Metastasis)
11/2017 - 11/2010
2Carcinogenesis
01/2021 - 12/2008
2Carcinoma (Carcinomatosis)
07/2008 - 06/2003
2Breast Neoplasms (Breast Cancer)
10/2006 - 06/2003
1Infections
01/2019
1Tuberous Sclerosis (Bourneville's Disease)
01/2015
1Atherosclerosis
06/2004
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2004
1Hypoxia (Hypoxemia)
02/2004
1Adenocarcinoma
02/2004
1Male Breast Neoplasms (Male Breast Cancer)
06/2003

Drug/Important Bio-Agent (IBA)

9Calcineurin InhibitorsIBA
01/2017 - 07/2008
8Proteins (Proteins, Gene)FDA Link
07/2020 - 06/2003
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2013 - 02/2004
7Heme Oxygenase-1IBA
12/2023 - 11/2010
6honokiolIBA
12/2023 - 09/2013
6Chemokine ReceptorsIBA
07/2020 - 10/2006
6Immunosuppressive Agents (Immunosuppressants)IBA
07/2020 - 07/2008
6Sirolimus (Rapamycin)FDA Link
07/2020 - 08/2010
5Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2023 - 03/2015
4LigandsIBA
01/2022 - 06/2004
4EnzymesIBA
01/2017 - 09/2011
3AntioxidantsIBA
12/2023 - 01/2019
3ChemokinesIBA
02/2014 - 10/2006
3CytokinesIBA
09/2013 - 08/2010
3Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2013 - 07/2008
3Small Interfering RNA (siRNA)IBA
11/2010 - 10/2006
2Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2017
2Nuclear Proteins (Protein, Nuclear)IBA
07/2020 - 02/2014
2Sorafenib (BAY 43-9006)FDA Link
01/2019 - 09/2012
2Annexin A5IBA
09/2011 - 11/2010
2Messenger RNA (mRNA)IBA
11/2010 - 07/2008
2CXCR3 ReceptorsIBA
12/2008 - 10/2006
1ranatachykinin CIBA
12/2023
1Transcription Factors (Transcription Factor)IBA
12/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2023
1cabozantinibIBA
12/2023
1Tryptophan (L-Tryptophan)FDA Link
01/2021
1Arginine (L-Arginine)FDA Link
01/2021
1Glutamine (L-Glutamine)FDA Link
01/2021
1B7-H1 AntigenIBA
11/2017
1Neutralizing AntibodiesIBA
03/2015
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
03/2015
1chelerythrineIBA
01/2015
1Mechanistic Target of Rapamycin Complex 1IBA
01/2015
1trans-sodium crocetinate (crocetin)IBA
01/2015
1Cytostatic AgentsIBA
01/2015
1p38 Mitogen-Activated Protein KinasesIBA
02/2014
1TOR Serine-Threonine KinasesIBA
01/2011
1Mechanistic Target of Rapamycin Complex 2IBA
12/2008
1Chemokine CXCL10IBA
10/2006
1protein kinase C zetaIBA
02/2004
1Insulin ReceptorIBA
02/2004
1Somatomedin Receptors (Somatomedin Receptor)IBA
02/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2004
1AntigensIBA
06/2003
1Glycoproteins (Glycoprotein)IBA
06/2003
1Complex MixturesIBA
06/2003
1tumor-associated antigen 72IBA
06/2003
1DEAE-CelluloseIBA
06/2003
1AntibodiesIBA
06/2003

Therapy/Procedure

6Therapeutics
12/2023 - 08/2010
5Organ Transplantation
01/2022 - 07/2008
5Transplantation
01/2022 - 07/2008
3Kidney Transplantation
01/2022 - 08/2012